The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Rothschild & Cie, startups are often financed by Venrock, Skyline Ventures, Mayfield Fund. The meaningful sponsors for the fund in investment in the same round are bioMerieux, Warburg Pincus, Venrock. In the next rounds fund is usually obtained by Scottish Equity Partners, Warburg Pincus, Rothschild & Co..
Deals in the range of 10 - 50 millions dollars are the general things for fund. This Rothschild & Cie works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2000. The top amount of exits for fund were in 2005. The average startup value when the investment from Rothschild & Cie is 10-50 millions dollars. The fund is constantly included in less than 2 deals per year.
Among the various public portfolio startups of the fund, we may underline ip.access, Sunesis Pharmaceuticals, MEDoctor The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Home Health Care.
| Fund Name | Location |
| Aegon | Den Haag, The Netherlands, Zuid-Holland |
| Alerion Ventures | Charleston, South Carolina, United States |
| Beijing Xing Pai Group | Beijing, Beijing, China |
| Cancer Research Technology | England, London, United Kingdom |
| Century Oak Capital | Liechtenstein, Oberland, Vaduz |
| Fujian Sheng Chuangxin Touzi | China, Fuzhou, Jiangxi |
| Hudson Valley Startup Fund | Kingston, New York, United States |
| ICICI Investment Management | India, Maharashtra, Mumbai |
| indaa.com.cn | Beijing, Beijing, China |
| Jingsheng Jiacheng Investment | - |
| Lewis & Clark Ventures | Missouri, St Louis, United States |
| LVP Life Science Ventures | - |
| Maj Invest Equity | Copenhagen, Denmark, Hovedstaden |
| McGraw Hill Financial | New York, New York, United States |
| Miyako Capital | Japan, Kyoto, Kyoto Prefecture |
| Northpoint Financial Group | California, Pleasanton, United States |
| SEICHO | Japan, Tokyo |
| UC Capital | Barcelona, Brazil, Rio Grande do Norte |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MEDoctor | $3M | 01 Aug 2000 | Wilmington, Delaware, United States | ||
Sunesis Pharmaceuticals | $60M | 11 Jul 2000 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MEDoctor | $3M | 01 Aug 2000 | Wilmington, Delaware, United States | ||
Sunesis Pharmaceuticals | $60M | 11 Jul 2000 | South San Francisco, California, United States |
